In a majority of melanomas (almost 60%), melanocyte biology and disease pathology are significantly influenced by the expression of the mutant forms of the BRAF gene, such as BRAFV599E, and the activation of the RAS/RAS/MAPK pathway which happens to be essential for melanoma cell viability and transformation [99]. This evidence concerns the gene BRAF and melanoma.